The Combined Effect of Systemic Immune-Inflammation Index and Type 2 Diabetes Mellitus on the Prognosis of Patients Undergoing Percutaneous Coronary Intervention: A Large-Scale Cohort Study

References

• Kong P, Cui ZY, Huang XF, Zhang DD, Guo RJ, Han M. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal Transduct Target Ther. 2022;7(1):131. doi:10.1038/s41392-022-00955-7
   PubMed Web of Science ®Google Scholar
• Soehnlein O, Libby P. Targeting inflammation in atherosclerosis - from experimental insights to the clinic. Nat Rev Drug Discov. 2021;20(8):589–610. doi:10.1038/s41573-021-00198-1
   PubMed Web of Science ®Google Scholar
• Kazemian S, Ahmadi R, Rafiei A, et al. The serum levels of il-36 in patients with coronary artery disease and their correlation with the serum levels of IL-32, IL-6, TNF-α, and oxidative stress. Int Arch Allergy Immunol. 2022;183(10):1137–1145. doi:10.1159/000525845
   PubMed Web of Science ®Google Scholar
• Guedeney P, Claessen BE, Kalkman DN, et al. Residual inflammatory risk in patients with low LDL cholesterol levels undergoing percutaneous coronary intervention. J Am Coll Cardiol. 2019;73(19):2401–2409. doi:10.1016/j.jacc.2019.01.077
   PubMed Web of Science ®Google Scholar
• Bäck M, Yurdagul A, Tabas I, Öörni K, Kovanen PT. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol. 2019;16(7):389–406. doi:10.1038/s41569-019-0169-2
   PubMed Web of Science ®Google Scholar
• He J, Bian X, Song C, et al. High neutrophil to lymphocyte ratio with type 2 diabetes mellitus predicts poor prognosis in patients undergoing percutaneous coronary intervention: a large-scale cohort study. Cardiovasc Diabetol. 2022;21(1):156. doi:10.1186/s12933-022-01583-9
   PubMed Web of Science ®Google Scholar
• Petzold T, Zhang Z, Ballesteros I, et al. Neutrophil “plucking” on megakaryocytes drives platelet production and boosts cardiovascular disease. Immunity. 2022;55(12):2285–2299.e7. doi:10.1016/j.immuni.2022.10.001
   PubMed Web of Science ®Google Scholar
• Ed Rainger G, Chimen M, Harrison MJ, et al. The role of platelets in the recruitment of leukocytes during vascular disease. Platelets. 2015;26(6):507–520. doi:10.3109/09537104.2015.1064881
   PubMed Web of Science ®Google Scholar
• Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol. 2021;18(9):666–682. doi:10.1038/s41569-021-00552-1
   PubMed Web of Science ®Google Scholar
• Akboga MK, Inanc IH, Sabanoglu C, et al. Systemic immune-inflammation index and c-reactive protein/albumin ratio could predict acute stent thrombosis and high syntax score in acute coronary syndrome. Angiology. 2023;74(7):693–701. doi:10.1177/00033197221125779
   PubMed Web of Science ®Google Scholar
• Candemir M, Kiziltunç E, Nurkoç S, Şahinarslan A. Relationship between systemic immune-inflammation index (sii) and the severity of stable coronary artery disease. Angiology. 2021;72(6):575–581. doi:10.1177/0003319720987743
   PubMed Web of Science ®Google Scholar
• Vatan MB, Çakmak AC, Ağaç S, Eynel E, Erkan H. The systemic immune-inflammation index predicts impaired myocardial perfusion and short-term mortality in st-segment elevation myocardial infarction patients. Angiology. 2023;74(4):365–373. doi:10.1177/00033197221106886
   PubMed Web of Science ®Google Scholar
• Zhao J, Lv H, Yin D, et al. Systemic immune-inflammation index predicts long-term outcomes in patients with three-vessel coronary disease after revascularization: results from a large cohort of 3561 patients. J Inflamm Res. 2022;15:5283–5292. doi:10.2147/JIR.S385990
   PubMed Web of Science ®Google Scholar
• Mosenzon O, Alguwaihes A, Leon JLA, et al. CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries. Cardiovasc Diabetol. 2021;20(1):154. doi:10.1186/s12933-021-01344-0
   PubMed Web of Science ®Google Scholar
• Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713–735. doi:10.1053/j.ajkd.2014.01.416
   PubMed Web of Science ®Google Scholar
• American Diabetes Association Professional Practice Committee. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17–S38. doi:10.2337/dc22-S002
   PubMedGoogle Scholar
• Williams B, Mancia G, Spiering W, et al. ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi:10.1093/eurheartj/ehy339
   PubMed Web of Science ®Google Scholar
• Mach F, Baigent C, Catapano AL, et al. ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2020;41(1):111–188. doi:10.1093/eurheartj/ehz455
   PubMed Web of Science ®Google Scholar
• Neumann FJ, Sousa-Uva M, Ahlsson A, et al. ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165. doi:10.1093/eurheartj/ehy394
   PubMed Web of Science ®Google Scholar
• Y-c M, Zuo L, Chen J-H, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–2944. doi:10.1681/ASN.2006040368
   PubMed Web of Science ®Google Scholar
• He J, Song C, Zhang R, Yuan S, Li J, Dou K. Discordance between neutrophil to lymphocyte ratio and high sensitivity c-reactive protein to predict clinical events in patients with stable coronary artery disease: a large-scale cohort study. J Inflamm Res. 2023;16:5439–5450. doi:10.2147/JIR.S428734
   PubMed Web of Science ®Google Scholar
• He J, Yang M, Song C, et al. Lipoprotein(a) is associated with recurrent cardiovascular events in patients with coronary artery disease and prediabetes or diabetes. J Endocrinol Invest. 2023. doi:10.1007/s40618-023-02203-3
   Web of Science ®Google Scholar
• He J, Song C, Wang H, Zhang R, Yuan S, Dou K. Diabetes mellitus with mild or moderate kidney dysfunction is associated with poor prognosis in patients with coronary artery disease: a large-scale cohort study. Diabet Res Clin Pract. 2023;200:110693. doi:10.1016/j.diabres.2023.110693
   PubMed Web of Science ®Google Scholar
• He J, Yuan S, Song C, et al. High triglyceride-glucose index predicts cardiovascular events in patients with coronary bifurcation lesions: a large-scale cohort study. Cardiovasc Diabetol. 2023;22(1):289. doi:10.1186/s12933-023-02016-x
   PubMed Web of Science ®Google Scholar
• Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212–6222. doi:10.1158/1078-0432.CCR-14-0442
   PubMed Web of Science ®Google Scholar
• Nøst TH, Alcala K, Urbarova I, et al. Systemic inflammation markers and cancer incidence in the UK biobank. Eur J Epidemiol. 2021;36(8):841–848. doi:10.1007/s10654-021-00752-6
   PubMed Web of Science ®Google Scholar
• Liu J, Li S, Zhang S, et al. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. J Clin Lab Anal. 2019;33(8):e22964. doi:10.1002/jcla.22964
   PubMed Web of Science ®Google Scholar
• Jomrich G, Paireder M, Kristo I, et al. High systemic immune-inflammation index is an adverse prognostic factor for patients with gastroesophageal adenocarcinoma. Ann Surg. 2021;273(3):532–541. doi:10.1097/SLA.0000000000003370
   PubMed Web of Science ®Google Scholar
• Adali MK, Buber I, Sen G, Yilmaz S. Relationship between systemic immune-inflammation index and coronary collateral circulation in patients with chronic total Occlusion. Arq Bras Cardiol. 2022;119(1):69–75. doi:10.36660/abc.20210414
   PubMed Web of Science ®Google Scholar
• Aksakal E, Aksu U, Birdal O, et al. Role of systemic immune-inflammatory index in predicting the development of in-hospital malignant ventricular arrhythmia in patients with st-elevated myocardial Infarction. Angiology. 2023;74(9):881–888. doi:10.1177/00033197221121435
   PubMed Web of Science ®Google Scholar
• Xia Y, Xia C, Wu L, Li Z, Li H, Zhang J. Systemic immune inflammation index (sii), system inflammation response index (siri) and risk of all-cause mortality and cardiovascular mortality: a 20-year follow-up cohort study of 42,875 us adults. J Clin Med. 2023;12(3):1128. doi:10.3390/jcm12031128
   PubMed Web of Science ®Google Scholar
• Xiao S, Wang Z, Zuo R, et al. Association of systemic immune inflammation index with all-cause, cardiovascular disease, and cancer-related mortality in patients with cardiovascular disease: a cross-sectional study. J Inflamm Res. 2023;16:941–961. doi:10.2147/JIR.S402227
   PubMed Web of Science ®Google Scholar
• He L, Xie X, Xue J, Xie H, Zhang Y. Association of the systemic immune-inflammation index with all-cause mortality in patients with arteriosclerotic cardiovascular disease. Front Cardiovasc Med. 2022;9:952953. doi:10.3389/fcvm.2022.952953
   PubMed Web of Science ®Google Scholar
• Yang YL, Wu CH, Hsu PF, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50(5):e13230. doi:10.1111/eci.13230
   PubMed Web of Science ®Google Scholar
• Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. Int J Mol Sci. 2020;21(5):1835. doi:10.3390/ijms21051835
   PubMed Web of Science ®Google Scholar
• Fadini GP, Menegazzo L, Scattolini V, Gintoli M, Albiero M, Avogaro A. A perspective on NETosis in diabetes and cardiometabolic disorders. Nutr, Metab Cardiovasc Dis. 2016;26(1):1–8. doi:10.1016/j.numecd.2015.11.008
   PubMed Web of Science ®Google Scholar
• Döring Y, Soehnlein O, Weber C. Neutrophil extracellular traps in atherosclerosis and atherothrombosis. Circ Res. 2017;120(4):736–743. doi:10.1161/CIRCRESAHA.116.309692
   PubMed Web of Science ®Google Scholar
• Menegazzo L, Ciciliot S, Poncina N, et al. NETosis is induced by high glucose and associated with type 2 diabetes. Acta Diabetol. 2015;52(3):497–503. doi:10.1007/s00592-014-0676-x
   PubMed Web of Science ®Google Scholar
• Joshi MB, Ahamed R, Hegde M, Nair AS, Ramachandra L, Satyamoorthy K. Glucose induces metabolic reprogramming in neutrophils during type 2 diabetes to form constitutive extracellular traps and decreased responsiveness to lipopolysaccharides. Biochim Biophys Acta Mol Basis Dis. 2020;1866(12):165940. doi:10.1016/j.bbadis.2020.165940
   PubMed Web of Science ®Google Scholar
• Warnatsch A, Ioannou M, Wang Q, Papayannopoulos V. Inflammation. neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science. 2015;349(6245):316–320. doi:10.1126/science.aaa8064
   PubMed Web of Science ®Google Scholar
• Josefs T, Barrett TJ, Brown EJ, et al. Neutrophil extracellular traps promote macrophage inflammation and impair atherosclerosis resolution in diabetic mice. JCI Insight. 2020;5(7):e134796. doi:10.1172/jci.insight.134796
   PubMed Web of Science ®Google Scholar
• Neergaard-Petersen S, Hvas AM, Kristensen SD, Grove EL. Platelets and antiplatelet therapy in patients with coronary artery disease and diabetes. Semin Thromb Hemost. 2016;42(3):234–241. doi:10.1055/s-0036-1571308
   PubMed Web of Science ®Google Scholar
• Ferreiro JL, Angiolillo DJ. Diabetes and antiplatelet therapy in acute coronary syndrome. Circulation. 2011;123(7):798–813. doi:10.1161/CIRCULATIONAHA.109.913376
   PubMed Web of Science ®Google Scholar
• Keating FK, Sobel BE, Schneider DJ. Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus. Am J Cardiol. 2003;92(11):1362–1365. doi:10.1016/j.amjcard.2003.08.033
   PubMed Web of Science ®Google Scholar
• Trovati M, Anfossi G. Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function. J Diabetes Complications. 2002;16(1):35–40. doi:10.1016/s1056-8727(01)00196-9
   PubMed Web of Science ®Google Scholar
• Wang J, Zhou D, Dai Z, Li X. Association between systemic immune-inflammation index and diabetic depression. Clin Interv Aging. 2021;16:97–105. doi:10.2147/CIA.S285000
   PubMed Web of Science ®Google Scholar
• Guo W, Song Y, Sun Y, et al. Systemic immune-inflammation index is associated with diabetic kidney disease in type 2 diabetes mellitus patients: evidence from NHANES 2011–2018. Front Endocrinol. 2022;13:1071465. doi:10.3389/fendo.2022.1071465
   PubMed Web of Science ®Google Scholar
• Song Y, Zhao Y, Shu Y, et al. Combination model of neutrophil to high-density lipoprotein ratio and system inflammation response index is more valuable for predicting peripheral arterial disease in type 2 diabetic patients: a cross-sectional study. Front Endocrinol. 2023;14:1100453. doi:10.3389/fendo.2023.1100453
   PubMed Web of Science ®Google Scholar
• Elbeyli A, Kurtul BE, Ozcan SC, Ozarslan Ozcan D. The diagnostic value of systemic immune-inflammation index in diabetic macular oedema. Clin Exp Optom. 2022;105(8):831–835. doi:10.1080/08164622.2021.1994337
   PubMed Web of Science ®Google Scholar
• Seo JW, Park SB. The association of hemoglobin a1c and fasting glucose levels with hs-crp in adults not diagnosed with diabetes from the KNHANES, 2017. J Diabetes Res. 2021;2021:5585938. doi:10.1155/2021/558593851
   PubMed Web of Science ®Google Scholar
• Elimam H, Abdulla AM, Taha IM. Inflammatory markers and control of type 2 diabetes mellitus. Diabetes Metab Syndr. 2019;13(1):800–804. doi:10.1016/j.dsx.2018.11.061
   PubMed Web of Science ®Google Scholar